George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Funnyguy,
Not sure what you mean by 'deserve any money invested'
I have been here since Aug 2012.
A long journey yes, even longer than l thought.
Companies have their ups and downs. These ups and downs do not change what the company has.
I believe in what they have created.
As you have no belief in what the company has created as indicated by your posting history, then what on heavens name prompted you to invest?
Regards
Funnyguy.
Opinion is one thing misleading or false information is something else.
This stated by you a few days back, can you confirm this is correct?
'We are not too far away from confirmation that Sareum have failed the tests and will not pursue.
On what factual data or statements have you based your above post, to give any credibility?
Correct me if l am wrong that if you have no such information to rely on, as l believe, then you have posted misleading information but also false information.
Regards
I meant to say, you deserve any money you have "invested " in SAR if you only know about it because you saw it on top risers board
For the record, i think another 10-15% drop tomorrow
And all the familiar names on here eg Celtic, i really hope SAR comes good for you as you deserve it. However, i am entitled to suggest it being a short-term play and expectation of a price drop. That in no way conflicts with what you think as everyone is entitled to opinion and then to make investment. For all the jonny come lately who post ridiculous things like "concerted derampers, people talking price down etc etc" you really should not be investing in shares as you have no clue about trading/investing.
When i post i am posting about SAR and my expectations so these postings are relevant. price going down is just opposite of going so trading takes into consideration both. Investors what the share price to go up and for the investors i genuinely wish you luck, but for those who are on this board and only know about SAR because they look at top risers , you actually deserve any money you have "invested" into SAR
Hi sadoldgit. Hope you are ok. Take my hat off to you , for taking on, all these derampers. Desperate scum, desperate lot.
I and you and many other long term holders, not going to be one bit bothered of this went down to 15p. I wait the data release soon, and hope it comes out suddenly, to catch all these shorters..... THE DATA WILL BE GOOD, VERY GOOD AND AM SURE WE WILL KICK ASS PSORIASIS.
DrMicho how much is that likely to cost?
Are you looking at Phase 2a or Phase 2a and 2b.
What is the Sareum strategy?
Why has Sareum chosen to go for phase2a and not phase 1b as initially planned?
Lot of newcomers on here clueless.
Regards
''legislative scrutiny has been weakened''
That's an understatement Basser1!
The AIM 'Regulator' is a feckless waste of space that it would appear spends its days sitting around with its thumb up its ass!!
Who here has EVER received a response to an email sent to them or read about some company or entity being fined?!?!
(I know that I sure as sh8t haven't!!! 🤔🤨 )
Is it any wonder both companies and investors are starting to desert the London Markets in ever increasing numbers!
https://www.standard.co.uk/business/london-stock-exchange-shares-ftse-100-crisis-equities-fund-outflows-b1145526.html
I am sure you and IG must be billionaire with so much of knowledge in predicting SP and you are here only to save innocent people from the trap of investing at highs.
Am I right in thinking that Ribverfort subscription shares of approx 2.3mil that began trading on Tuesday will be dribbled into the market at the highest price for obvious reasons they will allow the SP to rise on certain days and maximizing their returns we may see a recover in SP tomorrow?
Yes investihg genius
Last week when in spiked ,I called 32p high
Some " die hard " sar investors predicted 50 p
70 p
Then yesterday another spike ,I again predicted a fall from. 38 to 30
Yet when it hit 33 cando66 buys 7k worth
Which is now 5.5 K
Not the best investment decision
95 percent of people who invest in aim shares loose money ,and that will not ever change ,they chase one to another hoping for that ten bagger
Expecting a continuation of the re-rate after todays coordination attack on sp
Isn’t it about time we have an Investor meet we seem over due or are the BOD scared to face the shareholders difficult questions to be asked and we could be 2 months away from getting the data read out
GLA
Unfortunately, I dont see it myself as the phase 2 requires funding and we know what that does....
Agree should see a hard bounce up for SAR and STG ..See bags of potential in both
Hard bounce up tomorrow now that the merchants of doom will have had their fill back at this level!
Surfi- in our Agm it was stated that potential partners/buyers have said “show us your data” well this is coming imminently. Let’s see if the bod can attract a good deal - and I know the board have been drumming that drum for many years but now it’s time to deliver. Not a fan of SP by the way. Another thing for people to consider will be the imminent funding raise for phase 2 - this will hold us back a little.
Exactly, I was buying these at 0.4p via the Primary Bid offer in June 2019 and had been snapping them up for below .3p in 2015. It's interesting to note that the share price then was pretty comparable to where it is today, since the 50-1 consolidation of shares. If we get good news on the P1a trial this will soar back up again as it has done in the past. Maybe not by your 4,600% example but if we do get a significant licencing deal from a major player then 200p to 300p is not un-reasonable....
Good luck, Brighty
All good here Silver yes will be good to see you too along with the others from last year and see what they have made of what’s happened, like you said hopefully in a better position than we are now .Still hoping 1802 goes into tox studies this year and at least by the AGM we should know who the mystery pharma is who took on 737
GLA
We're down more than MATD is right now...and the yak has had a bad Rns this morning 🧐
Hi Gunner yes look forward to seeing you in December hopefully SAR will be in a different phase by then and things will be looking up. I wanted to ask about PH at the last AGM but as you rightly observe there was barely any time allowed! Maybe we go armed with chains and padlocks!!😵💫😵💫 Hope all is good with you .
Hi Silver hope all is well I think we know TM was happy with PH last time he spoke on the IM and would be nice to ask him that question and why he was ,also would be respectful of the BOD at the next AGM to not have a time bound meeting and should be pencilled in for all the morning or afternoon and hopefully they can answer the questions there and then from shareholders on the floor and questions submitted beforehand I think it it the least they can do especially as it’s been the shareholders that have saved this company I would also put it out there for more shareholders to try and attend the AGM as it is in their interest and is good to meet like minded people within SAR
Let’s hope 1801 data data data results is as good as we expect and we can build from there going forward
GLA
1. Those that understand this share will know that we gained x46 approx from .2p to 9p+ in pre consolidation money (or from 10p to 450p+ in post consolidation money). i.e. A 4,600% gain.
2. We had regular dilutions along the way but for those that invested, in particular, between 2018 and 2021 and who bought at the bottom at .2p and sold at 8 or 9p understood the bigger picture rather than a few 10 % here or a few 20% gains there. i.e. Big money was made on the x 4,600% rise and surprise surprise the current share price is back where it was pre-the mega rise. Just in time for data to be released.
3. Sareum is a company that has its global patent ducks in a row.
4. Sareum has already produced data showing that its lead candidate SDC-1801 is superior to Dexamethasone in a trial.
5. Sareum has shown that its science in combo with Astra Zeneca's WEE1, Merck’s Keytruda, Eli Lilly's Gemcitabine works.
6. We've not had any significant "fails" in 20 years.
7. The Phase 1a trial includes a single ascending dose study, a multiple ascending dose study and a food effects study. If the results are as good as we expect - and all the news has been encouraging to date - a big pharma is likely to swoop in with a licencing deal.
8. We already know that the safety and pharmacokinetics data from the initial cohorts in Part 1 of the SDC-1801 trial indicate a favourable profile and fully support oral dosing of patients once daily.
9. We have been briefed that the full safety data from the Phase 1a trial is expected to be available during Q2. We are in this period, so news could come at any time.
Therefore, those with a vision and a medium term strategy to "Mega Multi-Bag will not be that worried about the daily share price shenanigans and fluctuations. We've seen it all before.
I have written to Lauren Williams and Dr Parker (registered letter) to ask the current situation with RF in terms of outstanding liabilities. Also took the opportunity to ask how much PH had cost us since October 2021 and could they advise what they believe the benefits to SAR have been from the association with PH.
Colbalt there remains way to many unknowns and variables, will we get a Mad finish RNS or are we to wait until the end of June for full data, no guarantees that will be positive enough to move forwards, market has no idea if we can fund a P2a, market has no idea what’s happening with SRA737…..
@Nicely....As I used to say to my ex wife ....'One swallow doesn't make my summer', it was normally said when it was my birthday.
gla x